Peking University Shenzhen Hospital | China
Author Profile:
Scopus
Orcid
🌟Prof. Dr. Yajie Liu – A Pioneer in Radiation Oncology & Cancer Research Excellence
🎓 EARLY ACADEMIC PURSUITS
Dr. Yajie Liu began her medical journey with a Bachelor of Medicine (1985–1990) from Norman Bethune University of Medical Sciences. Driven by a deep interest in oncology, she completed her Master's degree in Oncology (1993–1996) from Harbin Medical University, followed by a prestigious Ph.D. in Oncology (1998–2001) at the Peking Union Medical College.
To expand her global medical perspective, she completed a Visiting Scholar Fellowship in Radiation Oncology at Chonnam National University Hospital in South Korea in 2010.
🏥 PROFESSIONAL ENDEAVORS
Dr. Liu's medical career spans over three decades of dedicated clinical service and leadership:
-
1990–1992: Resident Physician, ENT, First Workers' Hospital of Liaohe Petroleum Exploration Bureau
-
1992–1998: Resident & Attending Physician, Radiation Oncology, The Third Affiliated Hospital of Harbin Medical University
-
2001–2017: Progressed from Attending to Chief Physician and Deputy Director at Shenzhen People’s Hospital
-
2017–Present: Chief Physician and Director, Department of Radiation Oncology, Peking University Shenzhen Hospital
Her ascent to leadership reflects a consistent trajectory of clinical excellence and patient-centered care in oncology.
🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC IMAGING
Dr. Liu has led and co-led numerous research projects focused on:
-
Radiosensitization in Cancer Therapy
-
Hyperthermia and Serum Biomarkers
-
Radiation-Induced Brain Injury
-
Gene Assays for Breast Cancer Prognosis
-
Advanced Radiotherapy Strategies for Rectal and Colorectal Cancer
She has actively participated in national-level research, contributing to the Ministry of Science & Technology's high-impact projects on biomarkers and innovative radiotherapy techniques.
💡 RESEARCH FUNDING & PROJECT LEADERSHIP
As Principal Investigator (PI):
-
Shenzhen Science & Technology Bureau (4 Projects)
-
Shenzhen Health Commission (1 Project)
-
International Collaboration Grant (¥500K)
These funded projects demonstrate her innovative approach in blending clinical insight with technological advancement, especially in plasma therapy and hypoxic tumor sensitization.
🌐 PROFESSIONAL LEADERSHIP & ACADEMIC SERVICE
Dr. Liu holds key roles in multiple national and regional medical bodies:
-
Standing Committee Member, CRTOG
-
Committee Member, Radiotherapy Branch, Chinese Medical Doctor Association
-
Vice Chair, Lung Cancer Committee, Guangdong Women Doctors’ Association
-
Director, Radiotherapy Branch, Shenzhen Anti-Cancer Association
-
Council Member, Jiusan Society Shenzhen Chapter
Her positions reflect widespread recognition of her expertise and leadership in oncology.
📚 ACADEMIC CITES & COLLABORATIONS
While specific citation metrics are not provided here, Dr. Liu’s work on biomarkers, 21-gene assays, radiation injury, and colorectal cancer radiosensitization has contributed to national and international collaborations, significantly enriching the literature in radiation oncology.
🌍 IMPACT AND INFLUENCE
Dr. Liu's multidisciplinary research has influenced clinical protocols, improved patient outcomes, and inspired young oncologists across China. Her work on low-temperature plasma in radiosensitization reflects her commitment to cutting-edge translational oncology.
🔮 LEGACY AND FUTURE CONTRIBUTIONS
Dr. Yajie Liu's legacy is marked by:
-
Pioneering radiotherapy techniques
-
Mentoring future oncology leaders
-
Driving forward international research collaborations
Her future direction is expected to focus on precision oncology, AI-guided radiotherapy planning, and expanding patient-centered cancer care models.
📑 NOTABLE PUBLICATIONS
"Supplementing sialic acid analogs overcomes radiotherapy resistance in triple-negative breast cancer by exacerbating ER stress"
Authors: M Yang, D Shi, J Lyu, Y Pan, Y Lyv, X Chen, Y Ouyang, Y Liu, Y Li, L Song
Journal: Redox Biology
Year: 2025
"X-ray-activated nanoscintillators integrated with tumor-associated neutrophils polarization for improved radiotherapy in metastatic colorectal cancer"
Authors: H Li, J Zeng, Q You, M Zhang, Y Shi, X Yang, W Gu, Y Liu, N Hu, Y Wang, X Chen, J Mu
Journal: Biomaterials
Year: 2025